FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4543511000001104: Litarex 564mg modified-release tablets (Alpharma Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17858701000001111 Litarex 564mg modified-release tablets (Alpharma Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38431101000001115 Litarex 564mg modified-release tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Litarex 564mg modified-release tablets (Alpharma Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Is a Lithium citrate 564mg modified-release tablets true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has active ingredient Lithium citrate true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Is a Litarex true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has specific active ingredient Lithium citrate true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Litarex 564mg modified-release tablets (Alpharma Limited) 100 tablet Is pack of False Litarex 564mg modified-release tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Litarex 564mg modified-release tablets (Alpharma Limited) 100 tablet Has AMP True Litarex 564mg modified-release tablets (Alpharma Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start